The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know clinical studies of metformin the diabetes prevention program it prevents diabetes the UKPDS it prevents cardiovascular disease the Alzheimer they're two clinical studies to suggest that in mild cognitive impairment it improves some domain by the way like name recalling
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the two studies that looked at mci metformin for six months and one for nine months had decreased deterioration in some of the domains of alzheimer's for both of them name recalls which is a real problem for me
people of on metformin in clinical studies will not develop diabetes the dpp will it will prevent diabetes or in people with diabetes it will prevent cardiovascular disease that's the uk pds the association studies with cancer hundreds of studies on cancers and all kinds of cancers the association studies on alzheimer's and also some clinical studies on mci